Table 1 Characteristics of the patients at baseline

Age (years)

43.88 (10.31)

TC (mmol/l)

5.22 (0.93)

Sex (Female)

23 (25.6%)

TG (mmol/l)

2.47 (1.96)

Race or ethnicity

LDL-C (mmol/l)

3.02 (0.86)

 Han

84 (93.3%)

HDL-C (mmol/l)

1.15 (0.28)

 Others^a

6 (6.7%)

HCY (umol/l)

12.45 [10.90, 14.80]

Time of HTN (months)

12 [2, 36]

Plasma renin (pg/ml)

13.61 [7.84, 22.39]

Ever treated^b

4 (4.4%)

Plasma aldosterone (pg/ml)

167.40 [138.26, 219.74]

Family history of HTN

73 (81.1%)

TSH (uIU/ml)

2.37 (1.51)

Family history of early onset cardiovascular disease

8 (8.9%)

Urinary protein

Smoking

26 (28.9%)

 -

70 (77.8%)

Alcohol

8 (8.9%)

 +

19 (21.1%)

Diabetes

4 (4.4%)

 +  +

1 (1.1%)

Coronary heart disease

0

Sinus rhythm

90 (100.0%)

Cerebrovascular disease

0

SV1 + RV5 (mv)

2.77 (0.78)

Peripheral vascular disease

0

QT (ms)

373.08 (29.96)

Sleep apnea^c

64 (71.1%)

QTc (ms)

419.24 (22.83)

BMI (kg/m²)

25.54 (3.02)

LA (mm)

31.57 (3.25)

Waistline (cm)

88.37 (8.92)

RA (mm)

30.16 (2.69)

Statin use

21 (23.3%)

LV (mm)

45.61 (3.63)

Fibrate use

5 (5.6%)

RV (mm)

28.40 (2.86)

Metformin use

4 (4.4%)

IVS (mm)

11.04 (1.23)

Serum potassium (mmol/l)

4.07 (0.36)

LVPW (mm)

10.62 (1.08)

Blood sodium(mmol/l)

143.14 (2.09)

LVEF (%)

68.79 (5.76)

FBG (mmol/l)

5.45 (1.26)

E/A

0.95 (0.33)

Glycosylated hemoglobin (%)

5.81 (1.18)

Carotid plaque

22 (24.4%)

Serum creatinine (umol/l)

73.42 (13.24)

IMT (mm)

0.87 (0.17)

Serum uric acid (umol/l)

378.22 (86.28)

ABI

1.17 (0.07)

Serum urea (mmol/l)

4.53 (1.23)

baPWV (cm/s)

1741.26 (273.94)

eGFR (ml/min/1.73m²)

103.12 (12.15)

ABPM character

ALT (U/L)

39.96 (29.90)

 Dippers

41 (45.6%)

AST (U/L)

28.20 (12.24)

 Non-dippers

47 (52.2%)

TBL (umol/l)

14.31 (5.29)

 Reverse-dippers

2 (2.2%)

DBL(umol/l)

4.08 (1.58)